Skip to main content
Clinical Trials/NCT02072655
NCT02072655
Completed
N/A

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

University Hospital, Angers1 site in 1 country40 target enrollmentJanuary 2014
ConditionsLymphoma

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lymphoma
Sponsor
University Hospital, Angers
Enrollment
40
Locations
1
Primary Endpoint
Quality of life score
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase.

In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration .

This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
January 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Angers
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 to 65 years old
  • Hospitalized in the Hematology care unit in UH Angers
  • Initial Hodgkin lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma
  • Without previous socio-aesthetic care.

Exclusion Criteria

  • Age \<18 years old.
  • Patient protected by the law.
  • Patient at end of life.
  • Patient unable to respond to the questionnaire.
  • Previous Socio aesthetic care.

Outcomes

Primary Outcomes

Quality of life score

Time Frame: Change form baseline in Quality of life score at an average of 5 months (4 to 6 cycles of chemotherapy).

* For patients in control group, arbitrarily during their fifth cycle of chemotherapy * For patients in interventional group during the course of chemotherapy after the third socio-aesthetic care, or at the latest, at the sixth treatment.

Secondary Outcomes

  • Social life assessment(Change form baseline in social life assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).)
  • Coopersmith Self-esteem inventory(Change form baseline in Coopersmith Self-esteem inventory score at an average of 5 months (4 to 6 cycles of chemotherapy).)
  • Body Image Scale assessment(Change form baseline in body image scale assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).)

Study Sites (1)

Loading locations...

Similar Trials